Latest From PhageTech Inc.
In this month's issue of Start-Up, we profile Flow Forward, Intensity Therapeutics, Perimeter Medical Imaging, PhageTech and Pulmotect.
A handheld biosensor in development by PhageTech Inc. is designed to detect the presence of several biomarkers associated with the recurrence of bladder cancer from a small urine sample, without the need for expensive and time-consuming lab-based tests. The device could also monitor treatment.
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Venture Funding Deals column provides a comprehensive monthly review of emerging life science companies that have received venture funding, including companies within the In Vitro Diagnostics, Medical Devices, and Pharmaceuticals sectors. This month’s column covers deals announced September through October 2015.
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Medical Device Deals Update column is a survey of recent medtech M&A, alliance, and financing activity. This month’s column covers deals announced September-October 2015.
In Vitro Diagnostics
- Urine-based Testing
- Therapeutic Areas
- North America
- Parent & Subsidiaries
- PhageTech Inc.
- Senior Management
Richard Henson, CEO
Marc Kelly, CFO
Arlene Bumb, VP, Marketing & Bus Dev
- Contact Info
Phone: (714) 478-1670
5151 California Ave.
Irvine, CA 92617
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.